More about

Bisphosphonate

News
May 14, 2024
2 min read
Save

Risedronate discontinuation may increase mortality risk after hip fracture

Risedronate discontinuation may increase mortality risk after hip fracture

Older adults who sustain a hip fracture after discontinuing risedronate following at least 5 years of treatment adherence have a higher post-fracture mortality risk than those who continue using risedronate, according to study data.

News
January 19, 2024
3 min read
Save

FDA adds boxed warning of increased severe hypocalcemia risk for denosumab

FDA adds boxed warning of increased severe hypocalcemia risk for denosumab

The FDA has added a boxed warning for denosumab to advise patients with advanced chronic kidney disease of an increased risk for severe hypocalcemia, according to an FDA drug safety communication.

News
August 14, 2023
4 min watch
Save

VIDEO: Consider drug holiday, switch from bisphosphonate for osteoporosis therapy

VIDEO: Consider drug holiday, switch from bisphosphonate for osteoporosis therapy

SANTA FE, N.M. — In this video exclusive, Michael R. McClung, MD, discusses strategies for drug holidays and transitions between osteoporosis therapies.

News
March 17, 2023
2 min read
Save

Trabecular bone score less useful bone strength biomarker than BMD for older adults

Trabecular bone score less useful bone strength biomarker than BMD for older adults

Antiresorptive medications such as oral bisphosphonates have a minimal effect on change in lumbar spine trabecular bone score among older adults, according to a study published in The Journal of Bone and Mineral Research.

News
March 09, 2023
1 min read
Save

Bisphosphonate use prior to THA may be risk factor for periprosthetic fracture

Bisphosphonate use prior to THA may be risk factor for periprosthetic fracture

LAS VEGAS — Use of bisphosphonates prior to primary total hip arthroplasty may be an independent risk factor for periprosthetic fracture among patients with osteoporosis, according to results presented here.

News
January 04, 2023
3 min read
Save

ACP recommends bisphosphonates for men, postmenopausal women with primary osteoporosis

ACP recommends bisphosphonates for men, postmenopausal women with primary osteoporosis

In an update to its guidance on primary osteoporosis, ACP recommended bisphosphonates as a first line of defense to reduce fracture risk in men and postmenopausal women.

News
December 21, 2022
2 min read
Save

Bisphosphonates, denosumab recommended to treat adults with hypercalcemia of malignancy

Bisphosphonates, denosumab recommended to treat adults with hypercalcemia of malignancy

A new clinical practice guideline from the Endocrine Society recommends treatment with IV bisphosphonates or denosumab in addition to adequate hydration for adults with moderate hypercalcemia of malignancy.

News
July 28, 2022
2 min read
Save

Bisphosphonate use does not raise mortality risk with atypical femur fractures

Bisphosphonate use does not raise mortality risk with atypical femur fractures

Among South-East Asian adults, bisphosphonate use in is not associated with differences in clinical outcomes or mortality after an atypical femur fracture, according to study data published in Bone.

News
July 26, 2022
44 min listen
Save

SAPHO Part 2: An Abundance of Acronyms

SAPHO Part 2: An Abundance of Acronyms

What does the PAPA spectrum disorder teach us about SAPHO? Is SAPHO an autoinflammatory condition or part of the SpA spectrum? Why have antibiotics been used to treat this condition? Find out in this episode!

News
June 16, 2022
2 min read
Save

NSAIDs reduce efficacy of clodronate in preventing bone loss, fractures

NSAIDs reduce efficacy of clodronate in preventing bone loss, fractures

In a cohort of women, NSAID use significantly decreased the efficacy of the bisphosphonate clodronate for preventing bone loss and fractures, according to findings from a post hoc analysis.

View more